More PRNewswire
View Older Stories View Newer Stories-
Zetrix and Beitou Launch Digital ID & Driver's Licence Services on Blockchain
-
TECNO Launches Three Pioneering Technologies at its Annual Future Lens 2023 Event
-
Karyopharm Shares Data at ASH 2023 Showing Strong SVR and TSS Durability Observed from Phase 1 Study of Selinexor 60mg and Ruxolitinib in JAK Inhibitor (JAKi)-Naïve Myelofibrosis Patients, with no SV
-
Sustainability Empowerment, Brand Upgrade VIVOTEK among Taiwan's Best Global Brands
-
Nona Biosciences Announces Collaboration with Evive Biotech to Accelerate Antibody Discovery
-
Xinhua Silk Road: China's Bama Tea shares tea culture and seeks cooperation at Belt and Road forum
-
Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)
-
Antengene Announces the Study of Anti-CD24 Monoclonal Antibody ATG-031 Dosed Its First Patient in the United States
-
Maine Condo Project to Offer Turnkey Restoration Hardware Units
-
Astellas' VEOZA™ (fezolinetant) Approved by European Commission for Treatment of Vasomotor Symptoms Associated with Menopause
-
Belgian Commitment to Partnership Supports a New Frontier of Europe-US Space Research
-
Taiho Oncology Announces Presentation of Data From a U.S. Real-Word Study of Oral Decitabine and Cedazuridine
-
Belgium and Lockheed Martin Celebrate Rollout of First F-35A for Belgium
-
Remedy Plan Therapeutics to Showcase Novel NAMPT Inhibitor During Oral Presentation at 2023 American Society of Hematology (ASH) Annual Meeting
-
Empowering the Season of Giving: Annual Holiday Canteen Drive Brings Aid to Incarcerated Women
-
The Cigna Group Announces Significant Increase to Share Repurchase Program of $10 Billion
-
SAMARITAN'S PURSE DEPLOYS ASSESSMENT TEAM TO TENNESSEE AFTER DEADLY TORNADOES
-
Chroma Medicine Highlights Data Demonstrating Durable Multiplex Epigenetic Editing to Enhance Allogeneic CAR T at 65th ASH Annual Meeting
-
Poseida Therapeutics Presents Positive Early Results from its Phase 1 Trial of Allogeneic CAR-T P-BCMA-ALLO1 in Relapsed-Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) An
-
Aqua Bridge Group and Enertech launch Aqua Bridge Kuwait at COP28, in boost for local food systems and fisheries
-
Studies Highlight Both Novel Treatments and Enduring Value of Older Approaches
-
Sanofi and Minapharm Sign an Exclusive Agreement for Localizing the manufacture of Clexane®
-
Freedom, Equality and Justice Lead to Peace
-
The Arab Energy Fund Launches "50+", Graduate Training Program for Fresh Graduates to Develop Talents in the MENA Energy Sector
-
Lomi™ Helps the High Alert Institute Meet the White House-HHS Health Sector Climate Pledge
-
Essential Safety Tips for Shoppers During the Holiday Season by Fast Guard Service
-
Dizal's Golidocitinib Pivotal Trial Demonstrates Superior and Durable Clinical Benefits for Patients with r/r PTCL in Oral Presentation at 2023 ASH
-
Global Times: TV drama 'Welcome to Milele' represents decades-old China-Africa medical aid cooperation
-
2023 VAPORESSO CARE ECO GO GREEN - Global Carbon Neutral Program Kicked Off
-
Pudgy Penguins Announces Pudgy World Alpha Powered by zkSync at Art Basel Miami
-
Global Incubation Innovation Forces Gather in Lingang for World Top-Performing Incubator Forum 2023
-
Studies Uncover Drivers of Health Disparities and Opportunities to Enhance Equity
-
Studies Highlight Impacts of Applying New Technologies in Everyday Care
-
Research Reveals Opportunities to Better Address Blood Disorders Early in Life
-
OnlyFans Search Unveiled: Fanscout's Groundbreaking New Approach
-
Servier Showcases Leadership in Mutant Isocitrate Dehydrogenase (IDH) Inhibition Through New Data Spotlighting Real-World Treatment Patterns and Clinical Outcomes of Tibsovo® Use at ASH 2023
-
InvaGen Pharmaceuticals Issues Voluntary Nationwide Recall of Vigabatrin for Oral Solution, USP 500mg due to Leaking Sachets
-
WORKS Announces New Executive Director
-
"MET GALA" FOR LATINOS GATHERED THE MOST IMPORTANT 500+ LATINOS IN THE COUNTRY
-
New Hybrid Treatment Forces Cancer Cells to Starve
-
Last Legend Off the Line: 2023 Chrysler 300C Ends Production
-
The NDC Partnership Joins the COP28 and CBD COP15 Presidencies and Nearly 30 Countries and Coalitions Advancing Integrated Action for Climate and Nature
-
Blueprint Medicines' Leadership in Driving Continued Innovation in Systemic Mastocytosis Highlighted at 2023 ASH Annual Meeting
-
New Data for Bispecific Antibody Epcoritamab (DuoBody® CD3xCD20) Shows Strong, Durable Treatment Response for Patients with Difficult-To-Treat Relapsed/Refractory (R/R) Follicular Lymphoma (FL)
-
Bulleit Frontier Whiskey takes on Miami to celebrate the first year of the Bulleit Pioneer Project
-
Prism Specialties Experts Share How to Prepare Your Home for the Winter Season
-
International Center for Biosaline Agriculture & Schneider Electric Advance Youth & Women Roles in Sustainability at COP28
-
SUSTAINABLE MARKETS INITIATIVE AGRIBUSINESS TASK FORCE LAUNCHES BLENDED FINANCE FRAMEWORK TO MAKE REGENERATIVE FARMING MAINSTREAM
-
Swiss Heritage Meets French Haute Maroquinerie in HEIGS' Debut Collection
-
CGTN: China, Vietnam eye closer people-to-people bonds
